In the build up to the AI in Pharma Summit 2017 in Boston, MA in October, I caught up with Ed Addison from Cloud Pharmaceuticals to discuss what he thinks are the leading challenges pharma face in the adoption and implementation of AI.
Ed Addison co-founded Cloud Pharmaceuticals in 2009. Addison is a serial entrepreneur who founded three previous ventures, two of which successfully merged with public companies. He has a unique and strong blend of in-depth business and technical experience in biotechnology and in information technology. Addison holds an MS in Biomedical Engineering from Johns Hopkins University and MBA from Duke University Fuqua School of Business.
Download your copy of the interview with Ed by clicking the icon below: